- Home
- ZNTL vs NRIM Comparison
ZNTL vs NRIM Comparison
Compare ZNTL & NRIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZNTL
- NRIM
- Stock Information
- Founded
- ZNTL 2014
- NRIM 1990
- Country
- ZNTL United States
- NRIM United States
- Employees
- ZNTL N/A
- NRIM N/A
- Industry
- ZNTL Biotechnology: Pharmaceutical Preparations
- NRIM Savings Institutions
- Sector
- ZNTL Health Care
- NRIM Finance
- Exchange
- ZNTL Nasdaq
- NRIM Nasdaq
- Market Cap
- ZNTL 105.8M
- NRIM 514.9M
- IPO Year
- ZNTL 2020
- NRIM N/A
- Fundamental
- Price
- ZNTL $1.42
- NRIM $88.43
- Analyst Decision
- ZNTL Buy
- NRIM
- Analyst Count
- ZNTL 7
- NRIM 0
- Target Price
- ZNTL $8.46
- NRIM N/A
- AVG Volume (30 Days)
- ZNTL 793.4K
- NRIM 42.1K
- Earning Date
- ZNTL 11-11-2025
- NRIM 10-22-2025
- Dividend Yield
- ZNTL N/A
- NRIM 2.89%
- EPS Growth
- ZNTL N/A
- NRIM 38.28
- EPS
- ZNTL N/A
- NRIM 7.99
- Revenue
- ZNTL $26,865,000.00
- NRIM $175,041,000.00
- Revenue This Year
- ZNTL N/A
- NRIM N/A
- Revenue Next Year
- ZNTL N/A
- NRIM $8.63
- P/E Ratio
- ZNTL N/A
- NRIM $11.07
- Revenue Growth
- ZNTL N/A
- NRIM 28.34
- 52 Week Low
- ZNTL $1.01
- NRIM $63.68
- 52 Week High
- ZNTL $5.44
- NRIM $100.21
- Technical
- Relative Strength Index (RSI)
- ZNTL 39.87
- NRIM 41.80
- Support Level
- ZNTL $1.60
- NRIM $89.73
- Resistance Level
- ZNTL $2.02
- NRIM $92.95
- Average True Range (ATR)
- ZNTL 0.12
- NRIM 1.90
- MACD
- ZNTL -0.05
- NRIM -0.44
- Stochastic Oscillator
- ZNTL 3.23
- NRIM 13.97
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
About NRIM Northrim BanCorp Inc
Northrim BanCorp Inc is a bank holding company. The Company operates in three reportable segments: Community Banking, Home Mortgage Lending, and Specialty Finance. It generates maximum revenue from the Community Banking segment which offers loan and deposit products to business and consumer customers in its market areas and operates nearly 20 branches throughout Alaska.